Open an account

Beyond Air

XAIR · NASDAQ

$2.19+$0.055 (+2.58%)TodayMarket closed ·
Prev close $2.14

About XAIR

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The company is headquartered in Garden City, New York and currently employs 61 full-time employees. The company went IPO on 2019-05-07. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. The company has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The firm is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. The company has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.

Employees
61
Headquarters
Garden City, New York
Listed
May 7, 2019
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
beyondair.net

XAIR key statistics

Market cap
3.91M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
80.84K
Volume
17.71K
Open price
$2.15
High today
$2.29
Low today
$2.15
52 Week high
$53.20
52 Week low
$2.05

Beyond Air (XAIR) at a glance

As of Oct 20, 2026, Beyond Air (XAIR) shares are priced at $2.19, giving the company a market cap of 3.91M and a price-to-earnings ratio of 0.00.

Today the stock has traded between $2.15 and $2.29. The current price is 1.9% above the day's low and 4.4% below its high.

Volume so far is 17.71K shares, below the average of 80.84K shares a day.

Over the past year Beyond Air has ranged from $2.05 to $53.20, and now sits 0% of the way up that range.

Beyond Air met or beat analyst EPS estimates in 6 of the last 8 quarters. In Q2 FY26 it reported -$25.00 per share against an estimate of -$17.44.

The average analyst price target is $20.40, 831.5% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $20.40
Low
$10.10
Now
$2.19
High
$31.50

XAIR earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 6 of the last 8 quarters, by 14.8% on average.

  1. Q3 FY24: reported -$200.00 per share against an estimate of -$216.24
  2. Q4 FY24: reported -$144.00 per share against an estimate of -$194.21
  3. Q1 FY25: reported -$108.00 per share against an estimate of -$129.54
  4. Q2 FY25: reported -$112.00 per share against an estimate of -$115.87
  5. Q3 FY25: reported -$60.00 per share against an estimate of -$65.28
  6. Q4 FY25: reported -$36.00 per share against an estimate of -$49.78
  7. Q1 FY26: reported -$30.60 per share against an estimate of -$28.56
  8. Q2 FY26: reported -$25.00 per share against an estimate of -$17.44

XAIR news

  • Press releaseGlobe Newswire

    Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference

  • Press releaseGlobe Newswire

    Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update

  • Stock Market Today: Dow Jones, S&P 500 And Nasdaq Futures Slip As Tech Selloff Gathers Pace— Apple, Beyond Air In Focus (UPDATED)

  • Transcript: Beyond Air Q4 2026 Earnings Conference Call

  • Press releaseGlobe Newswire

    Beyond Air® Reports Fourth Quarter and Full Year 2026 Financial Results and Provides Corporate Update

  • Press releaseGlobe Newswire

    Beyond Air to Participate in the 38th Annual Roth Conference in March

  • Press releaseGlobe Newswire

    Beyond Air® Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update

  • Press releaseGlobe Newswire

    Beyond Air to Participate in Two Upcoming Healthcare Investor Conferences

Similar companies

Companies in the same industry as Beyond Air

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.